Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Dermatology, University of Alabama Birmingham 2013 - 2016
  • Internal Medicine, Boston University School of Medicine 2012 - 2013
  • M.D., University of Alabama School of Medicine 2012
  • B.S., University of Alabama Birmingham 2008
• 

  Previous Appointments & Affiliations

  • Assistant Professor of Dermatology, Dermatology, Clinical Science Departments 2017 - 2020
  • Medical Instructor in the Department of Dermatology, Dermatology, Clinical Science Departments 2016 - 2017
• Research
• 

  Selected Grants

  • UCB Hidradenitis Suppurativa - Extention awarded by UCB Pharma, Inc. 2021 - 2025
  • A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3041658 in Adults with Moderate-to-Severe Hidradenitis Suppurativa awarded by Lilly USA, LLC 2021 - 2023
  • Duke Skin of Color Fellowship awarded by Pfizer, Inc. 2021 - 2023
  • A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Bimekizumab in Study Participants with Moderate to Severe Hidradenitis Suppurativa awarded by UCB Pharma, Inc. 2020 - 2023
  • Racial variation in Sex Steroid effects in Women with Hidradenitis Suppurativa awarded by Skin of Color Society Foundation 2020 - 2023
  • Sex hormones in Hidradenitis Suppurativa awarded by Dermatology Foundation 2020 - 2022
  • A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Upadacitinib in Adult Subjects with Moderate to Severe Hidradenitis Suppurativa awarded by AbbVie Inc. 2020 - 2021
• 

  External Relationships

  • Eli Lilly & Co.
  • Huron Consulting
  • IQVIA/Chemocentryx
  • Pfizer Inc.
  • UCB Pharma
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Garg, Amit, Neeta Malviya, Andrew Strunk, Shari Wright, Afsaneh Alavi, Raed Alhusayen, Ali Alikhan, et al. “Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.” J Am Acad Dermatol 86, no. 5 (May 2022): 1092–1101. https://doi.org/10.1016/j.jaad.2021.01.059.
       Full Text  Link to Item
    • Jiang, Simon W., Jeffery T. Kwock, Beiyu Liu, Amy J. Petty, Aaron T. Zhao, Cynthia L. Green, and Tarannum Jaleel. “High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa.” Br J Dermatol, February 22, 2022. https://doi.org/10.1111/bjd.21066.
       Full Text  Link to Item
    • Kaakati, Rayan N., John Tanaka, Beiyu Liu, Rachael Ward, Amanda S. Macleod, Cynthia L. Green, and Tarannum Jaleel. “Atopic dermatitis is associated with hidradenitis suppurativa diagnosis: A single institution retrospective cohort study.” Jaad Int 4 (September 2021): 18–24. https://doi.org/10.1016/j.jdin.2021.04.006.
       Full Text  Link to Item
    • Mariottoni, Paula, Simon W. Jiang, Courtney A. Prestwood, Vaibhav Jain, Jutamas Suwanpradid, Melodi Javid Whitley, Margaret Coates, et al. “Single-Cell RNA Sequencing Reveals Cellular and Transcriptional Changes Associated With M1 Macrophage Polarization in Hidradenitis Suppurativa.” Front Med (Lausanne) 8 (2021): 665873. https://doi.org/10.3389/fmed.2021.665873.
       Full Text  Link to Item
    • Ward, Rachael A., Nneka S. Udechukwu, Maria A. Selim, and Tarannum Jaleel. “Vulvar and perineal verrucous changes complicating hidradenitis suppurativa after wide excision: a case and literature review.” Dermatol Online J 26, no. 7 (June 15, 2020).
       Link to Item
    • Puza, Charles J., Sarah A. Wolfe, and Tarannum Jaleel. “Pain Management in Patients With Hidradenitis Suppurativa Requiring Surgery.” Dermatol Surg 45, no. 10 (October 2019): 1327–30. https://doi.org/10.1097/DSS.0000000000001693.
       Full Text  Link to Item
    • Alikhan, Ali, Christopher Sayed, Afsaneh Alavi, Raed Alhusayen, Alain Brassard, Craig Burkhart, Karen Crowell, et al. “North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.” J Am Acad Dermatol 81, no. 1 (July 2019): 91–101. https://doi.org/10.1016/j.jaad.2019.02.068.
       Full Text  Link to Item
    • Alikhan, Ali, Christopher Sayed, Afsaneh Alavi, Raed Alhusayen, Alain Brassard, Craig Burkhart, Karen Crowell, et al. “North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.” J Am Acad Dermatol 81, no. 1 (July 2019): 76–90. https://doi.org/10.1016/j.jaad.2019.02.067.
       Full Text  Link to Item
    • Keeley, Jordan M., Stephanie L. Bevans, Tarannum Jaleel, and Naveed Sami. “Rituximab and low dose oral immune modulating treatment to maintain a sustained response in severe pemphigus patients.” J Dermatolog Treat 30, no. 4 (June 2019): 340–45. https://doi.org/10.1080/09546634.2018.1510173.
       Full Text  Link to Item
    • Wei, Jia, Tarannum Jaleel, Amanda S. MacLeod, and John S. Ji. “Inverted U-shaped relationship between vitamin D and ever-reported eczema in US adults.” Allergy 74, no. 5 (May 2019): 964–75. https://doi.org/10.1111/all.13708.
       Full Text  Link to Item
    • Coates, Margaret, Paula Mariottoni, David L. Corcoran, Hélène Fradin Kirshner, Tarannum Jaleel, David A. Brown, Stephen R. Brooks, John Murray, Maria I. Morasso, and Amanda S. MacLeod. “The skin transcriptome in hidradenitis suppurativa uncovers an antimicrobial and sweat gland gene signature which has distinct overlap with wounded skin.” Plos One 14, no. 5 (2019): e0216249. https://doi.org/10.1371/journal.pone.0216249.
       Full Text  Link to Item
    • Oak, Allen S. W., Tarannum Jaleel, Katherine Fening, Peter G. Pavlidakey, and Naveed Sami. “A case of scurvy associated with nilotinib.” J Cutan Pathol 43, no. 8 (August 2016): 725–26. https://doi.org/10.1111/cup.12715.
       Full Text  Link to Item
    • Jaleel, T., Y. Kwak, and N. Sami. “Clinical Approach to Diffuse Blisters.” Physician Assistant Clinics 1, no. 2 (April 1, 2016): 307–31. https://doi.org/10.1016/j.cpha.2015.12.007.
       Full Text
    • Jaleel, Tarannum, Craig Elmets, Allison Weinkle, Sama Kassira, and Boni Elewski. “Secukinumab (AIN-457) for the treatment of Psoriasis.” Expert Rev Clin Pharmacol 9, no. 2 (2016): 187–202. https://doi.org/10.1586/17512433.2016.1129894.
       Full Text  Link to Item
    • Jaleel, Tarannum, Young Kwak, and Naveed Sami. “Clinical Approach to Diffuse Blisters.” Med Clin North Am 99, no. 6 (November 2015): 1243–xii. https://doi.org/10.1016/j.mcna.2015.07.009.
       Full Text  Link to Item
    • Jaleel, T., C. Carney, and B. Elewski. “Cosmetic aspects of nail products and services.” Cosmetic Dermatology 25, no. 8 (August 1, 2012): 357–63.
    • Lewis, Wesley, Eva Simanyi, Hui Li, Camilla A. Thompson, Tahseen H. Nasti, Tarannum Jaleel, Hui Xu, and Nabiha Yusuf. “Regulation of ultraviolet radiation induced cutaneous photoimmunosuppression by toll-like receptor-4.” Arch Biochem Biophys 508, no. 2 (April 15, 2011): 171–77. https://doi.org/10.1016/j.abb.2011.01.005.
       Full Text  Link to Item
    • Sharan, Chakradhari, Sunil K. Halder, Chandrasekhar Thota, Tarannum Jaleel, Sangeeta Nair, and Ayman Al-Hendy. “Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase.” Fertil Steril 95, no. 1 (January 2011): 247–53. https://doi.org/10.1016/j.fertnstert.2010.07.1041.
       Full Text  Link to Item
    • Yusuf, Nabiha, Tahseen H. Nasti, Chun-Ming Huang, Brad S. Huber, Tarannum Jaleel, Hui-Yi Lin, Hui Xu, and Craig A. Elmets. “Heat shock proteins HSP27 and HSP70 are present in the skin and are important mediators of allergic contact hypersensitivity.” J Immunol 182, no. 1 (January 1, 2009): 675–83. https://doi.org/10.4049/jimmunol.182.1.675.
       Full Text  Link to Item

  • Conference Papers

    • Jiang, S. W., J. Kwock, A. J. Petty, A. T. Zhao, and T. Jaleel. “A retrospective case series of Ustekinumab therapy in patients with severe and recalcitrant Hidradenitis Suppurativa.” In Journal of Investigative Dermatology, 141:B17–B17, 2021.
       Link to Item
    • Mariottoni, P Rosa Coutinho Goulart Borges, M. Coates, D. Corcoran, H. F. Kirshner, T. Jaleel, D. A. Brown, and A. S. MacLeod. “The sweat gland antimicrobial peptide dermcidin is downregulated in hidradenitis suppurativa and non-healing skin wounds but upregulated in healing-wounds.” In Journal of Investigative Dermatology, 140:S40–S40, 2020.
       Link to Item
    • Ward, Rachael A., Rayan Kakaati, Beiyu Liu, Cindy Green, and Tarannum Jaleel. “Hidradenitis suppurativa is associated with increased odds of stroke, coronary artery disease, heart failure, and PAD: A population-based analysis in the United States.” In Journal of the American Academy of Dermatology, 81:AB1–AB1. MOSBY-ELSEVIER, 2019.
       Link to Item
    • Coates, M., D. Corcoran, P Rosa Coutinho Goulart Mariottoni, T. Jaleel, D. Brown, J. Murray, M. Morasso, and A. S. MacLeod. “The skin transcriptome in hidradenitis suppurativa uncovers an antimicrobial and sweat gland gene signature that has distinct overlap with wounded skin.” In Journal of Investigative Dermatology, 139:S162–S162. ELSEVIER SCIENCE INC, 2019.
       Link to Item
    • Kaakati, R., R. A. Ward, B. Liu, C. Green, and T. Jaleel. “LB1497 Association between hidradenitis suppurativa and atopic dermatitis.” In Journal of Investigative Dermatology, 138:B5–B5. Elsevier BV, 2018. https://doi.org/10.1016/j.jid.2018.06.027.
       Full Text
    • Puza, C. J., B. Liu, C. Green, S. A. Wolfe, and T. Jaleel. “1280 The role of surgery in hidradenitis suppurativa management.” In Journal of Investigative Dermatology, 138:S218–S218. Elsevier BV, 2018. https://doi.org/10.1016/j.jid.2018.03.1296.
       Full Text
    • Wei, J., T. Jaleel, A. MacLeod, and J. S. Ji. “341 Association between vitamin D and eczema among adults in the US National Health and Nutrition Examination Survey.” In Journal of Investigative Dermatology, 138:S58–S58. Elsevier BV, 2018. https://doi.org/10.1016/j.jid.2018.03.347.
       Full Text
    • Kassira, Sama, Tarannum Jaleel, and Naveed Sami. “Keloidal scleroderma: Case report and review.” In Journal of the American Academy of Dermatology, 74:AB82–AB82. MOSBY-ELSEVIER, 2016.
       Link to Item
    • Timares, L., T. Nasti, B. Cochran, T. Jaleel, N. Yusuf, and C. A. Elmets. “A new mouse model for studying the development of melanomas.” In Journal of Investigative Dermatology, 133:S238–S238. NATURE PUBLISHING GROUP, 2013.
       Link to Item
    • Nasti, T., T. Jaleel, and L. Timares. “Deficiency in IL-23, but not IL-12, promotes the development of melanocytic tumors with regional lymph node involvement in C3H/HeN mice.” In Journal of Investigative Dermatology, 132:S125–S125. NATURE PUBLISHING GROUP, 2012.
       Link to Item
    • Nasti, T., T. Jaleel, B. Cochran, L. Timares, and C. Elmets. “Deficiency in IL-23, but not IL-12, promotes the development of melanocytic tumors with regional lymph node involvement in C3H/HeN mice.” In Journal of Investigative Dermatology, 132:S133–S133. NATURE PUBLISHING GROUP, 2012.
       Link to Item
    • Muehleisen, Beda, Tara Jaleel, Katherine Radek, and Richard Gallo. “Dietary vitamin D3 protects against bacterial skin infection.” In Journal of Investigative Dermatology, 130:S34–S34. NATURE PUBLISHING GROUP, 2010.
       Link to Item
    • Muchleisen, B., T. Jaleel, K. Radek, and R. Gallo. “Dietary vitamin D3 protects against bacterial skin infection.” In Journal of Investigative Dermatology, 130:S121–S121. NATURE PUBLISHING GROUP, 2010.
       Link to Item
• Scholarly, Clinical, & Service Activities
• 

  Presentations & Appearances

  • Neurocristic Hamartoma: A Case Report. Annual Meeting. American Academy of Dermatology. March 21, 2015  2015
  • Pseudolymphoma. Quarterly Meeting. Alabama Dermatology Society. January 25, 2015  2015
  • Generalized Essential Telangiectasis. Quarterly Meeting. Alabama Dermatology Society. January 12, 2014  2014
• 

  Clinical Activities

  • General medical dermatology clinic (1/2 day per week)
    Hidradenitis suppurativa subspecialty clinic (1/2 day per week)
    Dermatology procedure clinic (1/2 per week)
    
    

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.